The FDA issued recent updates regarding drugs that are currently in shortage or have been discontinued:
- Aminocaproic Acid Injection, USP (Updated – Currently in Shortage)
- Amiodarone Tablets (New – Discontinuation)
- Asparaginase Erwinia Chrysanthemi (Erwinaze) (Updated – Currently in Shortage)
- Atenolol Tablets (Updated – Currently in Shortage)
- Atropine Sulfate Injection (Updated – Currently in Shortage)
- Bumetanide Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride and Epinephrine Injection, USP (Updated – Currently in Shortage)
- Bupivacaine Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Calcium Chloride Injection, USP (Updated – Currently in Shortage)
- Calcium Gluconate Injection (Updated – Currently in Shortage)
- Carbidopa and Levodopa Extended Release Tablets (Updated – Currently in Shortage)
- Cefepime Injection (Updated – Currently in Shortage)
- Cefotetan Disodium Injection (Updated – Currently in Shortage)
- Deferoxamine Mesylate for Injection, USP (Updated – Currently in Shortage)
- Dextrose 5% Injection Bags (Updated – Currently in Shortage)
- Dextrose 50% Injection (Updated – Currently in Shortage)
- Diazepam Injection, USP (Updated – Currently in Shortage)
- Diltiazem Hydrochloride (Updated – Currently in Shortage)
- Dobutamine Hydrochloride Injection (Updated – Currently in Shortage)
- Dopamine Hydrochloride Injection (Updated – Currently in Shortage)
- Dorzolamide Hydrochloride and Timolol Maleate (Cosopt) Ophthalmic Solution (Updated – Currently in Shortage)
- Dorzolamide Hydrochloride Ophthalmic Solution (Updated – Currently in Shortage)
- Epinephrine Injection, 0.1 mg/mL (Updated – Currently in Shortage)
- Etoposide Phosphate (Etopophos) Injection (Updated – Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated – Currently in Shortage)
- Fluoxetine Capsules (New – Discontinuation)
- Folic Acid Injection (Updated – Currently in Shortage)
- Heparin Sodium and Sodium Chloride 0.9% Injection (Updated – Currently in Shortage)
- Hydromorphone Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Imipenem and Cilastatin for Injection, USP (Updated – Currently in Shortage)
- Ketamine Injection (New – Currently in Shortage)
- Labetalol Hydrochloride Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection (Updated – Currently in Shortage)
- Lidocaine Hydrochloride (Xylocaine) Injection with Epinephrine (Updated – Currently in Shortage)
- Methylphenidate Hydrochloride (QUILLICHEW ER) Extended-Release Chewable Tablets (Updated – Currently in Shortage)
- Metoclopramide Injection, USP (Updated – Currently in Shortage)
- Metronidazole Injection, USP (Updated – Currently in Shortage)
- Morphine Sulfate Injection, USP (Updated – Currently in Shortage)
- Multi-Vitamin Infusion (Adult and Pediatric) (Updated – Currently in Shortage)
- Pantoprazole (Protonix) Powder for Injection (Updated – Currently in Shortage)
- Piperacillin and Tazobactam (Zosyn) Injection (Updated – Currently in Shortage)
- Potassium Chloride Injection (Updated – Currently in Shortage)
- Potassium Phosphate Injection (Updated – Currently in Shortage)
- Procainamide Hydrochloride Injection, USP (Updated – Currently in Shortage)
- Progesterone Injection, USP (Updated – Currently in Shortage)
- Rocuronium Bromide Injection (Updated – Currently in Shortage)
- Sodium Acetate Injection, USP (Updated – Currently in Shortage)
- Sodium Bicarbonate Injection, USP (Updated – Currently in Shortage)
- Sodium Chloride 0.9% Injection Bags (Updated – Currently in Shortage)
- Sodium Chloride 23.4% Injection (Updated – Currently in Shortage)
- Sodium Phosphate Injection (Updated – Currently in Shortage)
- Sterile Water (Updated – Currently in Shortage)
- Sumatriptan (Sumavel DosePro) Injection (New – Discontinuation)
- Triamterene and Hydrochlorothiazide Tablets (New – Discontinuation)
According to the FDA:
“A drug receives Resolved status when the Drug Shortages Staff (DSS) determines that the market is covered, based on information from all manufacturers. The market is considered covered when supply is available from at least one manufacturer to cover total market demand. However, some manufacturers may not have all presentations available. DSS monitors the supply of products with Resolved status. For the most current supply information, contact the manufacturers.”
(Source: U.S. Food & Drug Adminstration)
Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news!
